SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIGOLIN, Gian Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.684
EU - Europa 5.512
AS - Asia 3.681
SA - Sud America 16
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 2
Totale 23.915
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.609
CN - Cina 1.785
IT - Italia 1.668
UA - Ucraina 988
DE - Germania 964
SG - Singapore 852
TR - Turchia 750
GB - Regno Unito 490
FI - Finlandia 316
SE - Svezia 312
FR - Francia 303
PL - Polonia 142
ID - Indonesia 116
VN - Vietnam 108
RU - Federazione Russa 87
BE - Belgio 77
CA - Canada 60
CZ - Repubblica Ceca 49
NL - Olanda 39
IN - India 24
LT - Lituania 17
HK - Hong Kong 15
IE - Irlanda 11
IR - Iran 10
BR - Brasile 8
ES - Italia 8
EU - Europa 8
JP - Giappone 8
AU - Australia 7
CH - Svizzera 7
AT - Austria 6
MX - Messico 6
SV - El Salvador 6
KR - Corea 5
RO - Romania 5
EC - Ecuador 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
HU - Ungheria 3
IL - Israele 3
CO - Colombia 2
GR - Grecia 2
MD - Moldavia 2
PA - Panama 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
HR - Croazia 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 23.915
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.778
Fairfield 1.671
Houston 1.184
Jacksonville 1.118
Chandler 1.097
Santa Clara 877
Ashburn 835
Ann Arbor 790
Singapore 699
Seattle 660
Wilmington 642
Cambridge 561
Beijing 471
Izmir 436
Nanjing 368
Princeton 288
Ferrara 261
Milan 199
New York 196
Boardman 160
San Diego 157
Shanghai 152
Warsaw 132
Nanchang 116
Jakarta 115
Shenyang 112
Dong Ket 108
Bremen 100
Addison 99
Helsinki 82
Brussels 77
Rome 73
Los Angeles 71
Hebei 70
Munich 68
Jiaxing 67
Tianjin 63
Dearborn 62
Changsha 60
London 45
Falls Church 44
Jinan 43
Norwalk 41
Brno 38
Redwood City 36
Bologna 34
Mountain View 34
San Mateo 34
Toronto 33
Zhengzhou 32
Naples 27
Frankfurt am Main 24
Verona 24
Bari 23
Kunming 23
Augusta 22
Ningbo 22
Ottawa 21
Auburn Hills 19
Guangzhou 19
Washington 19
Florence 18
Haikou 18
Lappeenranta 18
Des Moines 17
Turin 16
Parma 15
Hefei 14
Orange 14
San Jose 14
Hangzhou 13
Hong Kong 13
Leawood 13
Monza 13
Taizhou 13
Tappahannock 13
Trieste 12
Genoa 11
Lanzhou 11
Lozzo Atestino 11
Monmouth Junction 11
Palermo 11
Changchun 10
Indiana 10
Olomouc 10
Padova 10
Redmond 10
Falkenstein 9
Napoli 9
Philadelphia 9
Dublin 8
Modena 8
Voghera 8
Brescia 7
Mumbai 7
Ardabil 6
Bolzano 6
Chicago 6
Chiswick 6
Fuzhou 6
Totale 17.166
Salva come PNG Salva come JPEG
Nome #
Ripristino dell’apoptosi mediata da p53: ruolo degli inibitori di MDM2. 819
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 193
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 180
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival 175
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 170
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 168
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 166
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 160
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 159
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 156
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 155
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 153
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 151
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 149
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 146
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 145
A case of disseminated Langerhans' cell histiocytosis treated with thalidomide 145
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 144
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 141
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 140
A case of advanced Hodgkin lymphoma with breast involvement treated with a combination of gemcitabine and pegylated liposomal doxorubicin. 139
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 139
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 138
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 137
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 137
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 137
Fisiologia piastrinica. 135
Secondary chromosome changes in mantle cell lymphoma: cytogenetic and fluorescence in situ hybridization studies. 135
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 135
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes 134
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 133
Minimal morphological criteria for defining bone marrow dysplasia: A basis for clinical implementation of WHO classification of myelodysplastic syndromes 133
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 133
Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Hodgkin's Lymphoma 132
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 132
Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings. 132
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 130
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 129
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia. 128
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 128
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 126
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 126
Dendritic cells and vascular endothelial growth factor in colorectal cancer: Correlations with clinicobiological findings 126
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis 125
null 124
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 124
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 124
Isolated thrombocytopenia by splenic sequestration in hemodialyzed patients 123
Exercise training and endothelial progenitor cells in haemodialysis patients 122
Dendritic cells in acute promyelocytic leukaemia 121
Delirium in acute promyelocytic leukemia patients: two case reports. 121
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 120
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia. 119
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients 119
Exercise capacity and circulating endothelial progenitor cells in hemodialysis patients 118
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells. 118
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 117
Hepatosplenic T-cell lymphoma (HSTCL). 116
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis. 116
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation 115
A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes 115
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 114
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 113
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 112
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 112
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 111
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 111
Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13) PDGFRB-NDE1 fusion 110
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 110
B-Cell chronic lymphocytic leukemia (B-CLL) with 14q32 translocations: haematological features and clinical outcome. 109
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 109
Differentiation of follicular dendritic sarcoma cells into functional myeloid-dendritic cell-like elements. 109
Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells 109
The role of rHuEpo in low-risk myelodysplastic syndrome patients 109
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 109
Cytogenetics in myelodysplastic syndromes: Old methods, new clues 109
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 108
INTEGRATION OF NOVEL GENE MUTATIONS INTO KARYOTYPE-BASED SUBGROUPS AS A PROGNOSTIC RISK STRATIFICATION TOOL IN CHRONIC LYMPHOCYTIC LEUKEMIA 108
Angiopoietin-2 Plasma Dosage Predicts Time to First Treatment (TTFT) and Overall Survival (OS) in Chronic Lymphocytic Leukemia. 107
null 106
Simian virus 40 efficiently infects human T lymphocytes and extends their lifespan 106
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile 106
CD34+CD33+ blast cells: Correlation with FAB subtypes 104
Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biological significance 104
Intestinal T-cell lymphoma 103
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 103
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study 103
CD34 quantitative flow cytometry study of the blastic population in acute leukemias. 102
Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: A randomized, placebo- controlled, double-blind, multicenter trial 102
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) 102
Study of prognosis in acute myeloid leukemias (AML) by cluster analysis 102
CLINICAL RESPONSE TO THE ASSOCIATION OF AZACITIDINE AND LENALIDOMIDE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES. A RANDOMIZED PHASE II MULTICENTER STUDY 102
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 102
Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with granulocyte colony stimulating factor and chemotherapy for autologous transplantation 101
Hemophagocytic Lymphohistiocytosis in a Patient with Relapsed Chronic Lymphocytic Leukemia Treated with Ibrutinib 101
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 101
The monocytic component in myelodysplastic syndromes. 100
null 100
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 100
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 100
Totale 13.155
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 17.161
Totale 139.651
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.962 0 0 0 0 0 0 376 439 339 477 238 93
2020/20213.589 237 265 208 343 141 328 155 374 87 518 575 358
2021/20222.856 207 338 119 141 217 146 156 164 96 243 255 774
2022/20232.771 334 144 108 304 459 371 128 273 380 25 164 81
2023/20241.610 138 155 76 50 99 244 74 98 38 50 114 474
2024/20252.610 182 174 543 283 814 579 35 0 0 0 0 0
Totale 24.363